USANA Health Sciences Inc... (USNA)
NYSE: USNA
· Real-Time Price · USD
30.16
-0.37 (-1.21%)
At close: Aug 15, 2025, 12:49 PM
USANA Health Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
February - January.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 |
Net Income | 9.29M | 4.48M | 10.61M | 10.43M | 16.54M | 16.77M | 11.35M | 17.29M | 18.38M | 12.79M | 14.93M | 19.16M | 22.47M | 20.32M | 27.33M | 38.23M | 30.62M |
Depreciation & Amortization | 10.24M | 5.88M | 5.56M | 5.7M | 5.08M | 4.87M | 5.16M | 5.14M | 5.22M | 5.25M | 5.42M | 5.13M | 5.61M | 5.66M | 5.48M | 5.56M | 5.49M |
Stock-Based Compensation | 2.88M | 3.61M | 3.54M | 3.73M | 3.67M | 3.64M | 3.67M | 3.67M | 3.61M | 3.52M | 3.08M | 3.56M | 3.18M | 3.26M | 3.45M | 3.85M | 3.74M |
Other Working Capital | -6.55M | -8.95M | 7.64M | -326K | -7.97M | -4.2M | 1.14M | -6.96M | -1.96M | 10.04M | 447K | -9.74M | -13.12M | -1.73M | 5.59M | 44K | -17.7M |
Other Non-Cash Items | 1.21M | 2K | 361K | 190K | 1.34M | 2.6M | 24K | -12K | 12.1M | 3K | 64K | 77K | -3K | 16K | 21.97M | -2K | 47K |
Deferred Income Tax | 1.35M | -2.7M | 871K | -7.46M | 2.55M | 1.47M | 808K | -8.58M | 3.56M | 1.13M | -1.49M | -10.49M | 3.67M | -367K | 3.17M | -8.74M | 2.97M |
Change in Working Capital | -9.5M | -5.5M | 8.59M | -4.6M | -11.49M | -3.33M | 1.23M | -7.44M | -17.94M | 17.77M | 7.12M | -2.81M | -15.22M | -3.97M | -1.95M | 266K | -23.21M |
Operating Cash Flow | 15.48M | 5.79M | 29.53M | 7.99M | 17.68M | 26.02M | 22.23M | 9.55M | 12.83M | 40.46M | 29.13M | 14.61M | 19.7M | 24.92M | 37.49M | 39.16M | 19.66M |
Capital Expenditures | -2.8M | -1.8M | -2.4M | -2.67M | -3.2M | -7.32M | -1.45M | -3.61M | -2.11M | -3.29M | -3.58M | -1.75M | -1.79M | -3.15M | -6.46M | -1.55M | -1.6M |
Cash Acquisitions | n/a | -203.34M | -3K | n/a | 3K | n/a | n/a | n/a | n/a | 3K | -6.53M | -6.53M | 3K | n/a | n/a | 2K | 13K |
Purchase of Investments | n/a | n/a | 870K | n/a | -870K | n/a | n/a | n/a | -1.27M | n/a | 6.53M | 6.53M | n/a | 1.55M | n/a | n/a | -1.55M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.55M | 4.55M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.07M | n/a | -806K | 1.13M | 3K | 2K | n/a | 3.79M | -1.27M | 3K | -4.55M | -6.53M | 3K | -1.55M | 12K | 55K | 64K |
Investing Cash Flow | -3.88M | -205.14M | -2.34M | -1.55M | -4.07M | -7.32M | -1.45M | 179K | -3.38M | -3.28M | -3.58M | -3.72M | -1.79M | -3.15M | -6.45M | -1.49M | -3.09M |
Debt Repayment | n/a | 23M | 1K | -1.32M | 537K | 792K | n/a | n/a | n/a | n/a | n/a | -10M | 10M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -12.3M | n/a | 31K | -31K | -9.44M | -134K | -11.6M | -55K | -2.86M | -150K | -44K | -301K | -25.38M | -31.91M | -46.77M | -31.55M | -67.61M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.17M | -74K | -79K | -31K | -3.04M | -134K | -42K | -55K | -3.2M | n/a | n/a | -301K | -4.21M | -534K | -60K | -116K | -2.87M |
Financial Cash Flow | -14.47M | 22.93M | -78K | -1.35M | -11.95M | 658K | -11.64M | -55K | -3.2M | -150K | -44K | -10.3M | -19.59M | -32.45M | -46.83M | -31.66M | -70.47M |
Net Cash Flow | -2.14M | -183.23M | 32.57M | 4.07M | -2.14M | 23.42M | 6.88M | 4.58M | 7.05M | 40.96M | 16.34M | -7.54M | -2.08M | -8.24M | -16.66M | 8.48M | -55.87M |
Free Cash Flow | 12.68M | 3.98M | 27.14M | 5.32M | 14.48M | 18.7M | 20.78M | 5.94M | 10.73M | 37.18M | 25.55M | 12.87M | 17.91M | 21.77M | 31.02M | 37.61M | 18.06M |